HIV Drug Based in Research by Sundquist Lab is Science’s 2024 Breakthrough of the Year
Lenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreLenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreMirror-reversed synthetic organisms could aid drug development–but could also interact with humans and the environment in unpredictable, potentially dangerous ways.
Read MoreAstronauts have a higher risk of blood clots. To learn why, scientists are sending blood cells to the International Space Station.
Read MorePreventing the protein’s activity causes parasites to die unusually rapidly.
Read MoreThe center aims to advance research, improve clinical care, support affected families, and reshape public understanding of stillbirth.
Read MoreResearchers aim to improve risk prediction and medical image analysis while ensuring reliability, privacy, and fairness.
Read MoreYue Lu aims to develop new ways to monitor health at organ-level resolution and population-level scale.
Read MoreBased at University of Utah Health, the center will focus on supporting healthy weight in rural and small-town communities.
Read MoreThe project will assess indoor air quality and develop effective, energy-saving air quality management plans for schools.
Read More